Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease - Wikidata - awgldk - TriplyDB

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

http://www.wikidata.org/entity/Q35848361

about

The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.CD25 preselective anti-HIV vectors for improved HIV gene therapy.Current and future approaches for control of graft-versus-host disease.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.Current issues in chronic graft-versus-host disease.Reconstitution of self-tolerance after hematopoietic stem cell transplantation High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Novel regulatory therapies for prevention of Graft-versus-host disease.Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis.Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma Biomarkers in chronic graft-versus-host disease Role of thymic stromal lymphopoietin (TSLP) in palifermin-mediated immune modulation and protection from acute murine graft-versus-host disease Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT Minimal change disease in graft versus host disease: a podocyte response to the graft?Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease.Aqueous extract of Caesalpinia sappan decelerates allograft rejection by inducing imbalance between CD4(+) CD25(+) T cells and Th17 cells CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations.Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

P2860

Q28066083-FC2AA309-F6AE-4850-BFF5-F262D1D6A5EF Q28072320-E96C9C29-B167-4412-AEF7-48C164D5C419 Q28076264-DCA4537D-91E9-4C4F-8315-A8D3C2DA1BF7 Q33528964-23F1E693-D8E2-4B81-91D5-40F363224D39 Q33586299-D811CAF6-02C7-478E-B37F-5CD881517619 Q33642625-ED73A062-D952-41CC-B18F-6526625EC2D5 Q33685495-7BDB8F7F-BAFD-4FEA-A487-7EE90A0AF5C2 Q33725411-ECBE0BDB-47AD-41F6-B76F-7838671D9702 Q33800533-102EA1CA-DF9F-42AF-8A0D-411A25A63296 Q33815631-272BD413-4BB9-48ED-9E98-E5D88ADFECC2 Q33917187-B8868AC9-E2FF-454E-AC87-AB779913A039 Q33945960-8227C226-6187-48F4-85BF-FB2935776E39 Q34135089-DE520633-5591-4899-8784-C86AFFF888AC Q34269481-F9A902AD-AE56-499C-AC25-77ED307EA8C2 Q34292984-98D03D03-AEB7-43CA-B915-277CC5D09469 Q34349909-3B3297B7-6862-48CB-92D9-F9BF63DB08A8 Q34462078-23C1E37B-1A42-4EE7-8DC5-EC6BAFC1AE9F Q34806652-A828368C-5459-422A-B94F-03B589555652 Q34870346-40B8AF75-A9F0-4BDC-AD18-B96752390EBA Q35029449-D398EB10-16D9-4789-9FD3-7B29E83B8B33 Q35053246-7E76BBFA-1ADA-4816-92C4-F1EF1F0E1395 Q35084404-3343D14F-DBB1-496B-96F7-A6AD2B58DBD0 Q35094374-628BC785-7906-4FF7-B641-46CD48AACA0D Q35097838-C9F4546C-7C01-4F15-A4F9-2700638012FC Q35232833-D54FD1E9-3CA7-43B4-953A-9CAFD74C4F08 Q35300908-331C2E52-07B8-49EB-9952-D701EFC01DE5 Q35525729-90715369-569B-4242-8811-EFF0077F5D56 Q35533376-FE0D527E-5911-48D1-B3D4-3675E996FD20 Q35553553-7E1CD6BB-70C6-436D-A0FB-B547226ED8D7 Q35575711-9B1AC479-8FCF-47CE-BAD1-4784AB7A6D9B Q35692054-E94CBCDA-03B3-43C6-B724-C548136F9135 Q35737769-C117FFE5-B7AB-41D4-9CC6-7C3387331397 Q35743830-D140D620-9F7C-400D-BA06-A726E8CD9384 Q35849935-0C795DCD-27A8-4E4F-A2F7-3BB50D1F1A83 Q35856933-8DDD0D9E-D24B-4A32-8128-CE9F66E0061D Q35865094-794D1EF6-AC84-4041-8531-A8B8A6FAC195 Q35870678-C2637AE4-F3BD-4C99-8E27-7ECEA17C689D Q35888837-C6E0BB04-BAAD-46C3-9A26-941A24B9D759 Q35989486-BB7D0490-2368-458F-AA1C-43980AA5947F Q36036340-66D58381-7557-4551-8918-3FDEBFF88A77

P2860

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

http://www.wikidata.org/entity/Q35848361

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@ast

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@en

type

label

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@ast

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@en

prefLabel

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@ast

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@en

P1433

Q35848361-2286CB44-A5A1-445B-B7E4-A56C3F209B32

P1476

Q35848361-8A0FBE17-C5DC-4A68-930A-DF9874C307F9

P2093

Q35848361-22839D7E-BC1E-4797-8228-72A8B8EA839D

Q35848361-25400BB6-D042-4FBA-834C-43EC3EB2484C

Q35848361-33818B06-BEAC-4727-88A3-F51585F73621

Q35848361-543801BE-67D3-458C-80E1-BE7EAEC74F7F

Q35848361-6340AFED-9F03-4AE2-BF9B-931CD4050B1A

Q35848361-6570F462-7D0D-4393-B054-D56DAB37270C

Q35848361-65D958ED-C4E9-4618-BD88-7057EAF85AD5

Q35848361-69B88810-9120-4B55-AB1D-B090DDEE4AD7

Q35848361-BC448BCB-64BC-4EE4-958E-B7E6D1FE9083

Q35848361-D8B79D86-BDEA-4977-9895-0FC23394AD8A

P2860

Q35848361-0ACB8D35-15D2-4AD5-83A3-61B0178E3DA0

Q35848361-10995842-4A2F-45DF-98C7-8729B9DDF6BB

Q35848361-15FDCCC6-2B4D-458F-A5F3-F5632C229CBD

Q35848361-243D50DB-771C-4B34-8E66-780F69C8BE23

Q35848361-30024B06-A7AD-4E1F-B811-FA8F38BD23CF

Q35848361-4C38C8FE-F546-4E7F-A250-0663549943F4

Q35848361-594F56F1-53D3-415C-BF32-91541CA00A8D

Q35848361-6659A6D3-CB37-43DE-A13B-3AC8CDE4F4DA

Q35848361-7201B684-CF53-4A2E-AB49-FBFE960A572A

Q35848361-75241089-BC0C-4051-89EB-54BD31D36D9F

P304

Q35848361-BB843524-8F17-4B81-8982-361B18BAA3E2

P31

Q35848361-C2E339FE-098E-4DC7-9805-C3DDB5B0C2EB

P356

Q35848361-A5CF0695-7C32-4B31-809E-2656BBE673F6

P407

Q35848361-17A5ECFD-8A0E-469A-9F00-BFF7273694BC

P433

Q35848361-D351A101-CD56-4CBA-A0E4-9BA666C2112E

P478

Q35848361-A317208A-5677-45A1-BC2B-7EA7094CBAE6

P577

Q35848361-B6D14D1D-275B-4F56-A1A8-76FC7B7BAA99

P5875

Q35848361-225E9536-0C80-4F66-92CA-53B3C5D8B56B

P698

Q35848361-E3ABE5AE-0381-45FB-9788-F47E9596A6F8

P932

Q35848361-59893C4F-92B4-4359-805B-77281C57FD25

P356

BLOOD-2005-03-1257

P1433

P1476

Reduced frequency of FOXP3+ CD ...... onic graft-versus-host disease

@en

P2093

Blair H Floyd

http://www.w3.org/2001/XMLSchema#string

Despina Litsa

http://www.w3.org/2001/XMLSchema#string

Edwin P Alyea

http://www.w3.org/2001/XMLSchema#string

Emmanuel Zorn

http://www.w3.org/2001/XMLSchema#string

Haesook T Kim

http://www.w3.org/2001/XMLSchema#string

Jerome Ritz

http://www.w3.org/2001/XMLSchema#string

Joseph H Antin

http://www.w3.org/2001/XMLSchema#string

Robert J Soiffer

http://www.w3.org/2001/XMLSchema#string

Roberto Bellucci

http://www.w3.org/2001/XMLSchema#string

Sankari Arumugarajah

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

An essential role for Scurfin in CD4+CD25+ T regulatory cells

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Chronic graft-versus-host disease: clinical manifestation and therapy.

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

P304

2903-2911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-03-1257

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7771938

http://www.w3.org/2001/XMLSchema#string

P698

15972448

http://www.w3.org/2001/XMLSchema#string

P932

1895303

http://www.w3.org/2001/XMLSchema#string